Washington, D.C. 20549


Under the Securities Exchange Act of 1934

(Amendment No. ___)*

PhaseBio Pharmaceuticals Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)


(CUSIP Number)


(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

 [_] Rule 13d-1(b)

 [_] Rule 13d-1(c)

 [x_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting
persons initial filing on this form with
respect to the subject class of securities, and for any subsequent
amendment containing information which would
alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall
not be deemed to be filed for the purpose of
Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise
subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act
(however, see the Notes).





Names of Reporting Persons

MAI Capital Management, LLC


Check the appropriate box if a member of a Group (see instructions)

(a) [ ]
(b) [ ]


Sec Use Only


Citizenship or Place of Organization

United States

Number of
Owned by Each
Reporting Person


Sole Voting Power



Shared Voting Power



Sole Dispositive Power



Shared Dispositive Power



Aggregate Amount Beneficially Owned by Each Reporting Person



Check box if the aggregate amount in row (9) excludes certain
shares (See Instructions)

[ ]


Percent of class represented by amount in row (9)



Type of Reporting Person (See Instructions)

Item 1.

(a) Name of Issuer: PhaseBio Pharmaceuticals Inc

(b) Address of Issuers Principal Executive Offices: 1
Great Valley Parkway, Suite 30, Malvern,
Pennsylvania 19355

Item 2.

(a) Name of Person Filing: MAI Capital Management, LLC
(b) Address of Principal Business Office or, if None,
Residence: 6050 Oak Tree Blvd Suite 500
Independence, OH 44131
(c) Citizenship: United States
(d) Title and Class of Securities: Common
(e) CUSIP No.: 717224109

Item 3. If this statement is filed pursuant to  240.13d-1(b)
or 240.13d-2(b) or (c), check whether the
person filing is a:

(a) [_] Broker or dealer registered under Section 15 of the Act;

(b) [_] Bank as defined in Section 3(a)(6) of the Act;

(c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

(d) [_] Investment company registered under Section 8 of the
Investment Company Act of 1940;

(e) [x_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f) [_] An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);

(g) [_] A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);

(h) [_] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act
(12 U.S.C. 1813);

(i) [_] A church plan that is excluded from the definition of an
investment company under
section 3(c)(14) of the Investment Company Act of 1940;

(j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

(k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution
in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify
the type of institution:

Item 4. Ownership

(a) Amount Beneficially Owned:

 (b) Percent of Class: 5.80%

 (c) Number of shares as to which such person has:

 (i) Sole power to vote or to direct the vote: 1,806,679

 (ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 2,675,376
(iv) Shared power to dispose or to direct the disposition of: 0

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased
to be the beneficial owner of more than five percent of the
class of securities, check the following [ ].

Item 6. Ownership of more than Five Percent on Behalf of Another Person.

Item 7. Identification and classification of the subsidiary which
acquired the security being reported on
by the parent holding company or control person.

Item 8. Identification and classification of members of the group.

Item 9. Notice of Dissolution of Group.

Item 10. Certifications.


After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this
statement is true, complete and correct.


Holly Cavalier  Chief Compliance Officer

The original statement shall be signed by each person on whose
behalf the statement is filed or his authorized
representative. If the statement is signed on behalf of a person
by his authorized representative (other than an
executive officer or general partner of this filing person),
evidence of the representative's authority to sign on
behalf of such person shall be filed with the statement, provided,
however, that a power of attorney for this
purpose which is already on file with the Commission may be
incorporated by reference. The name and any title
of each person who signs the statement shall be typed or printed
beneath his signature.

Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18
U.S.C. 1001).